{
    "name": "tebentafusp",
    "comment": "Rx",
    "other_names": [
        "Kimmtrak",
        "tebentafusp-tebn"
    ],
    "classes": [
        "ImmTACs"
    ],
    "source": "https://reference.medscape.com/drug/kimmtrak-tebentafusp-4000245",
    "pregnancy": {
        "common": [
            "Based on mechanism of action, fetal harm may occur when administered to pregnant females",
            "No data are available data on pregnant females",
            "Molecules of similar molecular weight can cross the placenta, resulting in fetal exposure; advise females of potential risks to fetus",
            "Verify pregnancy status in females of reproductive potential before initiating"
        ],
        "specific": [
            {
                "type": "Contraception",
                "description": [
                    "Females of reproductive potential: Use effective contraception during treatment and for 1 week following last dose"
                ]
            },
            {
                "type": "Animal data",
                "description": [
                    "No animal reproductive and developmental toxicity studies have been conducted"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "No data are available on presence of tebentafusp in human milk, effects on breastfed infants, or effects on milk production",
            "Advise patients not to breastfeed during treatment and for at least 1 week after last dose"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [
                " "
            ],
            "specific": [
                {
                    "type": "Cytokine release syndrome (CRS)",
                    "description": [
                        "CRS, which may be serious or life-threatening, occurred",
                        "Monitor for at least 16 hr following first 3 infusions and then as clinically indicated"
                    ]
                }
            ]
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Increases in AST/ALT were observed; in majority of patients experiencing elevated ALT/AST, occurred within the first 3 infusions; monitor AST, ALT, and total blood bilirubin before initiating and during treatment; withhold according to severity",
                "May cause fetal harm when administered to pregnant females",
                " "
            ],
            "specific": [
                {
                    "type": "CRS",
                    "description": [
                        "CRS occurred",
                        "May manifest as fever, hypotension, hypoxia, chills, nausea, vomiting, rash, elevated transaminases, fatigue, and headache",
                        "Ensure that healthcare providers have immediate access to medications and resuscitative equipment to manage CRS",
                        "Ensure patients are euvolemic before initiating ",
                        "Closely monitor for signs or symptoms of CRS following infusions ",
                        "Monitor fluid status, vital signs, and oxygenation level and provide appropriate therapy",
                        "Withhold or discontinue, depending on persistence and severity of CRS"
                    ]
                },
                {
                    "type": "Skin reactions",
                    "description": [
                        "Skin reactions (eg, rash, pruritus, cutaneous edema) reported",
                        "Median time to onset was 1 day; median time to improvement to Grade â‰¤1 was ~6 days",
                        "Monitor for skin reactions",
                        "If skin reactions occur, treat with antihistamine and topical or systemic steroids, based on persistence and severity of symptoms",
                        "Withhold or permanently discontinue, depending on severity of skin reactions"
                    ]
                },
                {
                    "type": "Drug interaction overview",
                    "description": [
                        "Elevation of certain proinflammatory cytokines may suppress CYP450 enzyme activities"
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Lymphocyte count decreased",
            "percent": "91"
        },
        {
            "name": "Cytokine release syndrome",
            "percent": "89"
        },
        {
            "name": "CRS",
            "percent": "87"
        },
        {
            "name": "Creatinine increased",
            "percent": "83"
        },
        {
            "name": "Rash",
            "percent": "76"
        },
        {
            "name": "Pyrexia",
            "percent": "69"
        },
        {
            "name": "Pruritus",
            "percent": "66"
        },
        {
            "name": "Glucose increased",
            "percent": "64"
        },
        {
            "name": "Fatigue",
            "percent": "55"
        },
        {
            "name": "AST increased",
            "percent": "52"
        },
        {
            "name": "ALT increased",
            "percent": "51"
        },
        {
            "name": "Hemoglobin decreased",
            "percent": "51"
        },
        {
            "name": "Phosphate decreased",
            "percent": "49"
        },
        {
            "name": "Nausea",
            "percent": "48"
        },
        {
            "name": "Chills",
            "percent": "47"
        },
        {
            "name": "Albumin decreased",
            "percent": "45"
        },
        {
            "name": "Abdominal pain",
            "percent": "45"
        },
        {
            "name": "Calcium decreased",
            "percent": "45"
        },
        {
            "name": "Edema",
            "percent": "39"
        },
        {
            "name": "Hypotension",
            "percent": "37"
        },
        {
            "name": "Lipase increased",
            "percent": "34"
        },
        {
            "name": "Magnesium decreased",
            "percent": "34"
        },
        {
            "name": "Alkaline phosphatase increased",
            "percent": "31"
        },
        {
            "name": "Dry skin",
            "percent": "31"
        },
        {
            "name": "Headache",
            "percent": "30"
        },
        {
            "name": "Vomiting",
            "percent": "30"
        },
        {
            "name": "Sodium decreased",
            "percent": "29"
        },
        {
            "name": "Potassium increased",
            "percent": "28"
        },
        {
            "name": "Skin hypopigmentation",
            "percent": "27"
        },
        {
            "name": "Bilirubin increased",
            "percent": "25"
        },
        {
            "name": "Diarrhea",
            "percent": "24"
        },
        {
            "name": "Erythema",
            "percent": "23"
        },
        {
            "name": "Amylase increased",
            "percent": "22"
        },
        {
            "name": "Arthralgia",
            "percent": "20"
        },
        {
            "name": "Hair color changes",
            "percent": "18"
        },
        {
            "name": "Glucose decreased",
            "percent": "17"
        },
        {
            "name": "Potassium decreased",
            "percent": "16"
        },
        {
            "name": "Platelet count decreased",
            "percent": "14"
        },
        {
            "name": "Neutrophil count decreased",
            "percent": "13"
        },
        {
            "name": "Calcium increased",
            "percent": "56"
        },
        {
            "name": "Lymphocyte count decreased",
            "percent": "18"
        },
        {
            "name": "Rash",
            "percent": "15"
        },
        {
            "name": "Lipase increased",
            "percent": "13"
        },
        {
            "name": "AST increased",
            "percent": "11"
        },
        {
            "name": "Phosphate decreased",
            "percent": "9"
        },
        {
            "name": "ALT increased",
            "percent": "6"
        },
        {
            "name": "Fatigue",
            "percent": "4.5"
        },
        {
            "name": "Pruritus",
            "percent": "4.1"
        },
        {
            "name": "Bilirubin increased",
            "percent": "4.1"
        },
        {
            "name": "Amylase increased",
            "percent": "3.7"
        },
        {
            "name": "Pyrexia",
            "percent": "3.3"
        },
        {
            "name": "Hypotension",
            "percent": "3.3"
        },
        {
            "name": "Glucose increased",
            "percent": "2.9"
        },
        {
            "name": "Abdominal pain",
            "percent": "2.9"
        },
        {
            "name": "Sodium decreased",
            "percent": "2.9"
        },
        {
            "name": "Alkaline phosphatase increased",
            "percent": "2.1"
        },
        {
            "name": "Albumin decreased",
            "percent": "2"
        },
        {
            "name": "Nausea",
            "percent": "2"
        },
        {
            "name": "Neutrophil count decreased",
            "percent": "1.6"
        },
        {
            "name": "Potassium increased",
            "percent": "1.6"
        },
        {
            "name": "Calcium decreased",
            "percent": "1.2"
        },
        {
            "name": "Diarrhea",
            "percent": "1.2"
        },
        {
            "name": "Vomiting",
            "percent": "0.8"
        },
        {
            "name": "CRS",
            "percent": "0.8"
        },
        {
            "name": "Arthralgia",
            "percent": "0.8"
        },
        {
            "name": "Potassium decreased",
            "percent": "0.8"
        },
        {
            "name": "Hemoglobin decreased",
            "percent": "0.4"
        },
        {
            "name": "Chills",
            "percent": "0.4"
        },
        {
            "name": "Headache",
            "percent": "0.4"
        },
        {
            "name": "Creatinine increased",
            "percent": "0.4"
        },
        {
            "name": "Glucose decreased",
            "percent": null
        }
    ]
}